UNSPSC 51111746: Ipilimumab

This classification denotes a monoclonal antibody with the molecular formula C6472H9972N1732O2004S40, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T8C155666, more generally known as ipilimumab. European Medicines Agency schedules ipilimumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29397. The term IPILIMUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56. Most nations schedule Ipilimumab under HS 30021020 and SITC 54163.

SMILES:. As of Q4 2014, IPILIMUMAB remains the US FDA Preferred Term for this commodity.. Ipilimumab bears US NLM identifiers UMLS ID C1367202 and NCI Concept Code C2654.

UNSPSC 51111746 Ipilimumab, a Commodity code, shows minimal alignment between its nominal scope—a specific immunotherapy drug—and the state and local procurement activity currently posted under it. Recent solicitations tagged to this code reflect purchase of naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products, and pharmacy benefit management services, none of which involves ipilimumab procurement. State and local buyers posting under this code include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The actual work being solicited spans emergency medical supplies, pharmaceuticals distributed through wholesaler networks, and direct-to-manufacturer prescription program design—a broad spectrum of health commodity and services purchasing rather than targeted acquisition of a single immunotherapy agent.

Relevant activity appears in Florida, Texas, and Minnesota. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: posted date and response date conflict in source). The City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with a $700,000 estimated contract value and a 5 percent bid discount for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance posted RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026, and contract effectiveness July 1, 2026. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer pharmacy initiatives, signaling early-stage market research rather than a committed procurement vehicle.